| |
|
 |
 |
|
Pharma Proff
enquiry@pharmaproff.com
+1-888-778-7886
|
|
 |
|
 |
Pharma Proff
created on: 7/12/2019
www.pharmaproff.com/
Pharma Proff, a brainchild of Prescient & Strategic (P&S) Intelligence Private Limited, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.
Latest Briefings:
| Hyperkalemia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results 249 views | | 7/26/2019, Hyperkalemia is referred to as increased levels of potassium in blood which results in cardiac arrest and death. Potassium levels above 5.1 mEq/l are considered as the hyperkalemia condition. read more | | |
| Wiskott-Aldrich Syndrome Therapeutics - Pipeline Analysis 2018 259 views | | 7/26/2019, Wiskott-Aldrich syndrome is a hereditary immunodeficiency disorder characterized by abnormal functioning of immune system and decreased ability to form blood clots. read more | | |
| Vaginitis Therapeutics - Pipeline Analysis 2018 244 views | | 7/26/2019, Vaginitis refers to the inflammation of vagina. It affects women of all ages but is most common during the reproductive years. Vaginitis occurs due to change in the balance of the yeast and bacteria that normally live in the vagina. read more | | |
| Uterine Fibroids Therapeutics - Pipeline Analysis 2018 243 views | | 7/26/2019, Uterine fibroids, also known as leiomyomas or myomas, are non-cancerous growths that develop from the muscle tissue of the uterus. The size, shape, and location of fibroids can vary greatly. read more | | |
| p53 Antigen Modulators Therapeutics- Pipeline Analysis 2018 232 views | | 7/26/2019, p53 is the tumor suppressor transcription factor that activates to various stimulus, including uncontrolled cell proliferation, oncogene over-expression, and DNA damage. read more | | |
| Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Inhibitor Therapeutics- Pipeline Analysis 2018 235 views | | 7/26/2019, Cytotoxic T-lymphocyte antigen-4 (CTLA-4) plays important role in the T-cell regulation at an early stage of naive T-cell activation, primarily in the lymph nodes. read more | | |
| Cyclophilin Inhibitors Therapeutics Pipeline Analysis 2018 232 views | | 7/26/2019, Cyclophilin befits in the group of protein that shows peptidyl-prolyl cis-trans isomerase activity, found in all types of cells. In humans, 16 cyclophilins have been identified till date. read more | | |
| Cell Cycle Inhibitors Therapeutics Pipeline Analysis 2018 256 views | | 7/26/2019, Cell cycle inhibitors include cyclin inhibitors and cyclin-dependent kinases (CDKs), which plays major role in developing new class of anti-cancer therapies. read more | | |
| Want to know positive clinical results of Androgen Receptor Antagonist therapeutics? 228 views | | 7/26/2019, Androgens are responsible for the development of male characteristics by binding to androgen receptors. Androgen receptor plays an important role in the development and progression of prostate cancer. read more | | |
| Alpha-Synuclein Inhibitor Therapeutics - Pipeline Analysis 2018 248 views | | 7/26/2019, Alpha-synuclein is a protein that is abundantly found in the brain. The minimal amount of alpha-synuclein is also found in the heart and other tissues. The protein is prominently found at the tips of the nerve cells. read more | | |
|
|
|
|
|
|
|
|